AAAAAA

   
Results: 1-7 |
Results: 7
Metabolism of ochratoxin A: Absence of formation of genotoxic derivatives by human and rat enzymes
Authors: Gautier, JC Richoz, J Welti, DH Markovic, J Gremaud, E Guengerich, FP Turesky, RJ
Citation: Jc. Gautier et al., Metabolism of ochratoxin A: Absence of formation of genotoxic derivatives by human and rat enzymes, CHEM RES T, 14(1), 2001, pp. 34-45
Oxidative damage and stress response from ochratoxin A exposure in rats
Authors: Gautier, JC Holzhaeuser, D Markovic, J Gremaud, E Schilter, B Turesky, RJ
Citation: Jc. Gautier et al., Oxidative damage and stress response from ochratoxin A exposure in rats, FREE RAD B, 30(10), 2001, pp. 1089-1098
The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia.
Authors: Ducimetiere, P Signeyrole, D Giral, P Hoog-Labouret, N Amarenco, P Chanu, B Chauvenet, M Coletti, M Dallongeville, J Durlach, V Kawka, G Krempf, M Leroux, G Mlika-Cabanne, N Monnier, L Paillard, F Rostoker, G Sicard, D Verny, C Voiriot, P Acquart, B Alquier, G Ankri, J Badoc, G Basdevant, A Belmin, J Berthezene, F Beucler, I Blanc, F Broustet, JP Bruckert, E Brun, JM Castaigne, A Charpentier, JM Andre, MC Cogneau, J Demeaux, JL Denolle, T Desson, JF Drahi, E Drouin, P Dumel, F Emmerich, J Farnier, M Fontbonne, A Forette, B Gambert, P Gautier, JC Guillausseau, PJ Hommel, M Janowski, M Le Goaziou, MF Lievre, M Le Quere, M Leys, D Marechaud, R Mas, JL Menard, J Michel, JM Mounier-Vehier, F Mottier, D Passa, P Pinel, JF Puel, J Raccah, D Renou, P Ribier, A Schlienger, JL Thomas, D Vallee, JP Veyssier-Belot, C Bouvenot, G Abadie, E Alexandre, JM Belorgey-Bismut, C Bergmann, JF Camelli, B Caulin, C Costagliola, D Denis, C Dupuis, B Fleurette, F Guillevin, L Hoog-Labouret, N Paintaud, G Rauss, A Poynard, T Rostoker, G Wong, O
Citation: P. Ducimetiere et al., The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia., J MAL VASC, 26(2), 2001, pp. 105-110
Validation of a new pertinent packing coefficient to estimate flow properties of pharmaceutical powders at a very early development stage, by comparison with mercury intrusion and classical flowability methods
Authors: Gabaude, CMD Gautier, JC Saudemon, P Chulia, D
Citation: Cmd. Gabaude et al., Validation of a new pertinent packing coefficient to estimate flow properties of pharmaceutical powders at a very early development stage, by comparison with mercury intrusion and classical flowability methods, J MATER SCI, 36(7), 2001, pp. 1763-1773
Human CYP2B6: expression, inducibility and catalytic activities
Authors: Gervot, L Rochat, B Gautier, JC Bohnenstengel, F Kroemer, H de Berardinis, V Martin, H Beaune, P de Waziers, I
Citation: L. Gervot et al., Human CYP2B6: expression, inducibility and catalytic activities, PHARMACOGEN, 9(3), 1999, pp. 295-306
The lyotropic polymorphism of two pharmacologically active molecules
Authors: Bouligand, Y Boury, F Pech, B Benoit, JP Gautier, JC Proust, JE
Citation: Y. Bouligand et al., The lyotropic polymorphism of two pharmacologically active molecules, LIQ CRYST, 26(9), 1999, pp. 1281-1293
Effects of true density, compacted mass, compression speed, and punch deformation on the mean yield pressure
Authors: Gabaude, CMD Guillot, M Gautier, JC Saudemon, P Chulia, D
Citation: Cmd. Gabaude et al., Effects of true density, compacted mass, compression speed, and punch deformation on the mean yield pressure, J PHARM SCI, 88(7), 1999, pp. 725-730
Risultati: 1-7 |